![From QSR to QMSR: Meeting FDA’s New Requirements From QSR to QMSR: Meeting FDA’s New Requirements](https://www.fdanews.com/ext/resources/Book-Covers-NEW/From-QSR-to-QMSR-500.png?height=200&t=1714569011&width=200)
Home » ACADIA PHARMACEUTICALS OFFICIALLY OPENS NEW CHEMISTRY R&D FACILITY IN SWEDEN
ACADIA PHARMACEUTICALS OFFICIALLY OPENS NEW CHEMISTRY R&D FACILITY IN SWEDEN
September 16, 2005
ACADIA Pharmaceuticals Inc. (Nasdaq: ACAD -- News), a biopharmaceutical company utilizing innovative technology to fuel drug discovery and clinical development of novel treatments for central nervous system disorders, today officially opened its modern chemistry research and development facility in Malmo, Sweden. The new facility consolidates ACADIA's presence in Scandinavia and provides increased access to a highly skilled and well-educated workforce in the biotechnology hub of the Medicon Valley region.
Yahoo News (http://biz.yahoo.com/prnews/050916/laf005.html?.v=24)
KEYWORDS Daily International Pharma Alert
Upcoming Events
-
21Oct